Literature DB >> 16921545

NeuroD and reaggregation induce beta-cell specific gene expression in cultured hepatocytes.

Shigeru Yatoh1, Tomoyuki Akashi, Phillip P Chan, Hideaki Kaneto, Arun Sharma, Susan Bonner-Weir, Gordon C Weir.   

Abstract

BACKGROUND: Our goal was to convert adult mouse hepatocytes to pancreatic beta-cells. METHODS AND
RESULTS: To facilitate conversion, cultured primary hepatocytes were dedifferentiated by the removal of dexamethasone (Dex) from the culture media. Removal of Dex caused detachment of hepatocytes from the culture dish, but the addition of betacellulin prevented this from happening. With the combination of lack of Dex and addition of betacellulin, albumin mRNA levels decreased. Cultured hepatocytes had a faint expression of insulin 2 mRNA, Nkx 6.1 and Pax 6 mRNA. Dedifferentiated hepatocytes were transduced with adenoviruses expressing NeuroD1, Ngn 3, or Pax 4. NeuroD1 transduction increased the insulin 2 mRNA but caused detachment of cells. However, when hepatocytes were allowed to reaggregate for 4 and 6 days in hydrophobic plates after transduction with NeuroD1, further increases of insulin 2 mRNA were found along with induction of PDX-1, IAPP, NeuroD1, Ngn3, Pax 4, Isl-1, PC1, PC2 and islet glucokinase. Additionally, glucagon, pancreatic polypeptide and somatostatin expression were induced, but neither elastase 1 nor insulin 1 mRNA could be detected. Ngn 3 and Pax 4 had effects similar to NeuroD1, but did not increase insulin 2 mRNA as much as NeuroD1.
CONCLUSION: We conclude that the combination of NeuroD1 and reaggregation promotes cultured dedifferentiated hepatocytes to differentiate towards a pancreatic beta-cell phenotype. (c) 2006 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 16921545     DOI: 10.1002/dmrr.678

Source DB:  PubMed          Journal:  Diabetes Metab Res Rev        ISSN: 1520-7552            Impact factor:   4.876


  9 in total

Review 1.  The quest for tissue stem cells in the pancreas and other organs, and their application in beta-cell replacement.

Authors:  Isabelle Houbracken; Luc Bouwens
Journal:  Rev Diabet Stud       Date:  2010-08-10

Review 2.  The use of β-cell transcription factors in engineering artificial β cells from non-pancreatic tissue.

Authors:  D Gerace; R Martiniello-Wilks; B A O'Brien; A M Simpson
Journal:  Gene Ther       Date:  2014-10-23       Impact factor: 5.250

3.  OVO homologue-like 1 (Ovol1) transcription factor: a novel target of neurogenin-3 in rodent pancreas.

Authors:  A Vetere; W-C Li; F Paroni; K Juhl; L Guo; W Nishimura; X Dai; S Bonner-Weir; A Sharma
Journal:  Diabetologia       Date:  2009-10-31       Impact factor: 10.122

4.  Pax6 regulates the proglucagon processing enzyme PC2 and its chaperone 7B2.

Authors:  Liora S Katz; Yvan Gosmain; Eric Marthinet; Jacques Philippe
Journal:  Mol Cell Biol       Date:  2009-02-17       Impact factor: 4.272

5.  Generation of islet-like cells from mouse gall bladder by direct ex vivo reprogramming.

Authors:  Raymond D Hickey; Feorillo Galivo; Jonathan Schug; Michael A Brehm; Annelise Haft; Yuhan Wang; Eric Benedetti; Guoqiang Gu; Mark A Magnuson; Leonard D Shultz; Eric Lagasse; Dale L Greiner; Klaus H Kaestner; Markus Grompe
Journal:  Stem Cell Res       Date:  2013-02-18       Impact factor: 2.020

Review 6.  Direct Lineage Reprogramming: Harnessing Cell Plasticity between Liver and Pancreas.

Authors:  Silvia Ruzittu; David Willnow; Francesca M Spagnoli
Journal:  Cold Spring Harb Perspect Biol       Date:  2020-07-01       Impact factor: 9.708

7.  Bioluminescence imaging of β cells and intrahepatic insulin gene activity under normal and pathological conditions.

Authors:  Tokio Katsumata; Hisashi Oishi; Yukari Sekiguchi; Haruka Nagasaki; Dhouha Daassi; Pei-Han Tai; Masatsugu Ema; Takashi Kudo; Satoru Takahashi
Journal:  PLoS One       Date:  2013-04-04       Impact factor: 3.240

8.  Generation of functional insulin-producing cells from neonatal porcine liver-derived cells by PDX1/VP16, BETA2/NeuroD and MafA.

Authors:  Dong-Sik Ham; Juyoung Shin; Ji-Won Kim; Heon-Seok Park; Jae-Hyoung Cho; Kun-Ho Yoon
Journal:  PLoS One       Date:  2013-11-15       Impact factor: 3.240

Review 9.  Plant-Derived Compounds Targeting Pancreatic Beta Cells for the Treatment of Diabetes.

Authors:  Yoon Sin Oh
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-26       Impact factor: 2.629

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.